JP2021102644A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021102644A5 JP2021102644A5 JP2021054632A JP2021054632A JP2021102644A5 JP 2021102644 A5 JP2021102644 A5 JP 2021102644A5 JP 2021054632 A JP2021054632 A JP 2021054632A JP 2021054632 A JP2021054632 A JP 2021054632A JP 2021102644 A5 JP2021102644 A5 JP 2021102644A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- pharmaceutical composition
- serum
- per unit
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002966 serum Anatomy 0.000 claims description 18
- 201000004681 Psoriasis Diseases 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 238000000034 method Methods 0.000 description 17
- 230000003902 lesion Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022175999A JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361789777P | 2013-03-15 | 2013-03-15 | |
| US61/789,777 | 2013-03-15 | ||
| JP2019172758A JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019172758A Division JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022175999A Division JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021102644A JP2021102644A (ja) | 2021-07-15 |
| JP2021102644A5 true JP2021102644A5 (enExample) | 2021-09-02 |
Family
ID=50336511
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500381A Pending JP2016517408A (ja) | 2013-03-15 | 2014-02-25 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2019172758A Pending JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2021054632A Pending JP2021102644A (ja) | 2013-03-15 | 2021-03-29 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2022175999A Withdrawn JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500381A Pending JP2016517408A (ja) | 2013-03-15 | 2014-02-25 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2019172758A Pending JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022175999A Withdrawn JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20160060337A1 (enExample) |
| EP (2) | EP2968488A1 (enExample) |
| JP (4) | JP2016517408A (enExample) |
| KR (1) | KR20150128858A (enExample) |
| CN (1) | CN105209064A (enExample) |
| AP (1) | AP2015008803A0 (enExample) |
| AU (3) | AU2014238148A1 (enExample) |
| CA (1) | CA2906382A1 (enExample) |
| CL (1) | CL2015002723A1 (enExample) |
| CR (1) | CR20150572A (enExample) |
| EA (1) | EA201591581A1 (enExample) |
| HK (1) | HK1219425A1 (enExample) |
| IL (2) | IL241342A0 (enExample) |
| PH (2) | PH12015502129A1 (enExample) |
| SG (2) | SG10201804954UA (enExample) |
| TN (1) | TN2015000403A1 (enExample) |
| WO (1) | WO2014149425A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2635601B1 (en) | 2010-11-04 | 2016-07-20 | Boehringer Ingelheim International GmbH | Anti-il-23 antibodies |
| WO2013165791A1 (en) | 2012-05-03 | 2013-11-07 | Boehringer Ingelheim International Gmbh | Anti-il-23p19 antibodies |
| EP3172339A1 (en) | 2014-07-24 | 2017-05-31 | Boehringer Ingelheim International GmbH | Biomarkers useful in the treatment of il-23a related diseases |
| US10059763B2 (en) | 2014-09-03 | 2018-08-28 | Boehringer Ingelheim International Gmbh | Compound targeting IL-23A and TNF-alpha and uses thereof |
| IL307578A (en) * | 2015-02-04 | 2023-12-01 | Boehringer Ingelheim Int | Methods of treating inflammatory diseases |
| US10765724B2 (en) * | 2016-03-29 | 2020-09-08 | Janssen Biotech, Inc. | Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody |
| AU2017250583A1 (en) * | 2016-04-15 | 2018-08-16 | Boehringer Ingelheim International Gmbh | Methods of treating inflammatory diseases |
| JP7634474B2 (ja) * | 2018-07-18 | 2025-02-21 | ヤンセン バイオテツク，インコーポレーテツド | 抗ｉｌ２３特異的抗体で治療した後の持続応答予測因子 |
| KR20210091209A (ko) * | 2018-11-05 | 2021-07-21 | 머크 샤프 앤드 돔 코포레이션 | 암의 치료를 위한 항-tigit 항체의 투여 요법 |
| EP3941934A4 (en) * | 2019-03-18 | 2022-12-07 | Janssen Biotech, Inc. | METHODS OF TREATMENT OF PSORIASIS IN CHILDREN WITH ANTI-IL12/IL23 ANTIBODIES |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| CO4810232A1 (es) | 1997-07-25 | 1999-06-30 | Schering Corp | Citoquinas de mamiferos y sus secuencias codificadoras |
| ES2410406T3 (es) | 2005-06-30 | 2013-07-01 | Janssen Biotech, Inc. | Anticuerpos anti-IL-23, composiciones, procedimientos y usos |
| EP1937721B1 (en) | 2005-08-25 | 2010-07-28 | Eli Lilly And Company | Anti-il-23 antibodies |
| US20070050011A1 (en) | 2005-08-26 | 2007-03-01 | Medlogics Device Corporation | Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs |
| HUE032131T2 (en) | 2005-08-31 | 2017-09-28 | Merck Sharp & Dohme | Constructed anti-IL-23 antibodies |
| AU2006330410A1 (en) * | 2005-12-28 | 2007-07-05 | Centocor, Inc. | Markers and methods for assessing and treating psoriasis and related disorders |
| EP3219328B1 (en) | 2005-12-29 | 2020-06-17 | Janssen Biotech, Inc. | Human anti-il-23 antibodies, compositions, method and uses |
| AU2007260787A1 (en) | 2006-06-13 | 2007-12-21 | Zymogenetics, Inc | IL-17 and IL-23 antagonists and methods of using the same |
| EP2064242A1 (en) * | 2007-02-23 | 2009-06-03 | Schering Corporation | Engineered anti-il-23p19 antibodies |
| ATE554791T1 (de) | 2007-02-23 | 2012-05-15 | Schering Corp | Gentechnisch hergestellte anti-il-23p19- antikörper |
| AR068723A1 (es) | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| WO2009082624A2 (en) | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| US8557239B2 (en) * | 2009-09-14 | 2013-10-15 | Abbvie Inc. | Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23 |
| TWI461210B (zh) * | 2008-03-18 | 2014-11-21 | Abbvie Inc | 治療牛皮癬的方法 |
| WO2010002776A2 (en) | 2008-06-30 | 2010-01-07 | Black & Decker Inc. | Cord protector for power tools |
| WO2010027766A1 (en) | 2008-08-27 | 2010-03-11 | Schering Corporation | Lyophilized formulatons of engineered anti-il-23p19 antibodies |
| WO2010115786A1 (en) | 2009-04-01 | 2010-10-14 | Glaxo Group Limited | Anti-il-23 immunoglobulins |
| WO2010142534A1 (en) | 2009-05-27 | 2010-12-16 | Ablynx Nv | Biparatopic protein constructs directed against il-23 |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| WO2011088120A1 (en) | 2010-01-15 | 2011-07-21 | Amgen Inc. | Antibody formulation and therapeutic regimens |
| US9127057B2 (en) | 2010-07-20 | 2015-09-08 | Teva Pharmaceuticals Ausralia Pty Ltd | Anti-IL-23 heterodimer specific antibodies |
| CN103813804A (zh) * | 2010-10-06 | 2014-05-21 | Abbvie公司 | 用于治疗银屑病的方法 |
| CN103154031A (zh) * | 2010-10-08 | 2013-06-12 | 诺华有限公司 | 利用il-17拮抗剂治疗牛皮癣的方法 |
| EP2635601B1 (en) | 2010-11-04 | 2016-07-20 | Boehringer Ingelheim International GmbH | Anti-il-23 antibodies |
-
2014
- 2014-02-25 US US14/776,222 patent/US20160060337A1/en not_active Abandoned
- 2014-02-25 AP AP2015008803A patent/AP2015008803A0/xx unknown
- 2014-02-25 JP JP2016500381A patent/JP2016517408A/ja active Pending
- 2014-02-25 HK HK16107479.7A patent/HK1219425A1/zh unknown
- 2014-02-25 EA EA201591581A patent/EA201591581A1/ru unknown
- 2014-02-25 CA CA2906382A patent/CA2906382A1/en not_active Abandoned
- 2014-02-25 CN CN201480015797.0A patent/CN105209064A/zh active Pending
- 2014-02-25 WO PCT/US2014/018293 patent/WO2014149425A1/en not_active Ceased
- 2014-02-25 EP EP14711352.6A patent/EP2968488A1/en not_active Withdrawn
- 2014-02-25 AU AU2014238148A patent/AU2014238148A1/en not_active Abandoned
- 2014-02-25 SG SG10201804954UA patent/SG10201804954UA/en unknown
- 2014-02-25 EP EP19206477.2A patent/EP3689369A1/en not_active Withdrawn
- 2014-02-25 SG SG11201507482UA patent/SG11201507482UA/en unknown
- 2014-02-25 KR KR1020157027833A patent/KR20150128858A/ko not_active Ceased
-
2015
- 2015-09-09 TN TN2015000403A patent/TN2015000403A1/en unknown
- 2015-09-09 IL IL241342A patent/IL241342A0/en unknown
- 2015-09-15 CL CL2015002723A patent/CL2015002723A1/es unknown
- 2015-09-15 PH PH12015502129A patent/PH12015502129A1/en unknown
- 2015-10-15 CR CR20150572A patent/CR20150572A/es unknown
-
2019
- 2019-01-11 AU AU2019200206A patent/AU2019200206A1/en not_active Abandoned
- 2019-09-24 JP JP2019172758A patent/JP2020063237A/ja active Pending
- 2019-10-10 US US16/598,714 patent/US20200277368A1/en not_active Abandoned
- 2019-11-28 PH PH12019502700A patent/PH12019502700A1/en unknown
-
2020
- 2020-06-03 IL IL275093A patent/IL275093A/en unknown
- 2020-11-18 AU AU2020270495A patent/AU2020270495A1/en not_active Abandoned
-
2021
- 2021-03-29 JP JP2021054632A patent/JP2021102644A/ja active Pending
-
2022
- 2022-01-13 US US17/574,980 patent/US20220135668A1/en not_active Abandoned
- 2022-11-02 JP JP2022175999A patent/JP2023011815A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021102644A5 (enExample) | ||
| JP5129122B2 (ja) | 癌治療のための抗体およびグルココルチコイドの組み合わせ | |
| AU2014337385B2 (en) | Chimeric antigen receptor T cell switches and uses thereof | |
| JP2019509351A5 (enExample) | ||
| JP2018168183A (ja) | Ｔ制御性細胞の増殖または枯渇方法 | |
| US20220000872A1 (en) | Method of enhancing immune-based therapy | |
| TWI894144B (zh) | 藉由投予il-33拮抗劑治療或預防哮喘之方法 | |
| JP2006527193A5 (enExample) | ||
| JP2013543501A5 (enExample) | ||
| JP2011513492A (ja) | 硝子体内注射のための低粘度、高凝集トリアムシノロンアセトニド懸濁剤 | |
| JP2012510965A (ja) | 結腸癌発生を予防または低減する方法 | |
| Ruggieri et al. | Ponesimod in the treatment of relapsing forms of multiple sclerosis: An update on the emerging clinical data | |
| RU2014105288A (ru) | Способы и композиции для лечения астмы с использованием антител против il-13 | |
| WO2022052874A1 (zh) | 西奥罗尼联合免疫检查点抑制剂在抗肿瘤治疗中的应用 | |
| JP2020528449A5 (enExample) | ||
| BR112020017445A2 (pt) | anticorpos anti cd6 para tratar asma severa | |
| CN108498802A (zh) | 用于治疗非小细胞肺癌的药物组合物及其制剂 | |
| JP6038486B2 (ja) | 台湾グリーンプロポリス抽出物を含む薬剤および栄養補給剤 | |
| JP2006514681A5 (enExample) | ||
| JP2016510766A (ja) | １型糖尿病の処置及び／又は予防のための方法及び組成物 | |
| WO2016119308A1 (zh) | 一种抗肿瘤制剂及其制备方法 | |
| CN110859959A (zh) | 抗pd-1抗体联合紫杉醇和铂类化合物在制备治疗食管癌的药物中的用途 | |
| KR20240158980A (ko) | 유기 화합물 | |
| TW202421660A (zh) | 藉由投與il-4r拮抗劑來治療嗜伊紅性食道炎的方法 | |
| CN115337310A (zh) | 一种抗炎剂在制备治疗或预防病毒性肝炎药物的应用 |